TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway
Authors
Keywords
TNFAIP8, NSCLC, Proliferation, Cisplatin chemoresistance, MDM2/p53 pathway
Journal
Cell Communication and Signaling
Volume 16, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-07-31
DOI
10.1186/s12964-018-0254-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Overexpression of TNFAIP8 is associated with tumor aggressiveness and poor prognosis in patients with invasive ductal breast carcinoma
- (2017) Min Xiao et al. HUMAN PATHOLOGY
- Contribution of genetic factors to platinum-based chemotherapy sensitivity and prognosis of non-small cell lung cancer
- (2017) Cristina Pérez-Ramírez et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Cancer treatment and survivorship statistics, 2016
- (2016) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The novel p53 target TNFAIP8 variant 2 is increased in cancer and offsets p53-dependent tumor suppression
- (2016) Julie M Lowe et al. CELL DEATH AND DIFFERENTIATION
- Association between the expression levels of tumor necrosis factor-α-induced protein 8 and the prognosis of patients with gastric adenocarcinoma
- (2016) LING CHEN et al. Experimental and Therapeutic Medicine
- Augmentation of Response to Chemotherapy by microRNA-506 Through Regulation of RAD51 in Serous Ovarian Cancers
- (2015) Guoyan Liu et al. JNCI-Journal of the National Cancer Institute
- p53 in survival, death and metabolic health: a lifeguard with a licence to kill
- (2015) Flore Kruiswijk et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Augmentation of Response to Chemotherapy by microRNA-506 Through Regulation of RAD51 in Serous Ovarian Cancers
- (2015) Guoyan Liu et al. JNCI-Journal of the National Cancer Institute
- Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy
- (2014) Ivana Sullivan et al. CANCER LETTERS
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- TNFAIP8 overexpression is associated with lymph node metastasis and poor prognosis in intestinal-type gastric adenocarcinoma
- (2014) Ming Yang et al. HISTOPATHOLOGY
- TNFAIP8 overexpression is associated with platinum resistance in epithelial ovarian cancers with optimal cytoreduction
- (2014) Tianbo Liu et al. HUMAN PATHOLOGY
- Correlation of TNFAIP8 overexpression with the proliferation, metastasis, and disease-free survival in endometrial cancer
- (2014) Tianbo Liu et al. TUMOR BIOLOGY
- TNFAIP8 as a predictor of metastasis and a novel prognostic biomarker in patients with epithelial ovarian cancer
- (2013) T Liu et al. BRITISH JOURNAL OF CANCER
- The significance of TNFAIP8 in prostate cancer response to radiation and docetaxel and disease recurrence
- (2012) Chuanbo Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- Tissue Platinum Concentration and Tumor Response in Non–Small-Cell Lung Cancer
- (2012) Eric S. Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- SCC-S2 is overexpressed in colon cancers and regulates cell proliferation
- (2012) Zhifeng Miao et al. TUMOR BIOLOGY
- TNFAIP8 Overexpression: Clinical Relevance to Esophageal Squamous Cell Carcinoma
- (2011) Yuni Elsa Hadisaputri et al. ANNALS OF SURGICAL ONCOLOGY
- Chemotherapy and Survival Benefit in Elderly Patients With Advanced Non–Small-Cell Lung Cancer
- (2010) Amy J. Davidoff et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now